Volume 3, Issue 3 (Autumn 2000)
J Arak Uni Med Sci 2000, 3(3): 18-23 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fani A. Prevalence and Background Risk Factors of Acute Renal Failure (ARF) in Intensive Care Unit (ICU) Patients of Vali-Asr Hospital Since JAN 21, 1997 TO AUG 22 1999. J Arak Uni Med Sci 2000; 3 (3) :18-23
URL: http://jams.arakmu.ac.ir/article-1-6628-en.html
URL: http://jams.arakmu.ac.ir/article-1-6628-en.html
School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Abstract: (1528 Views)
Acute renal failure (ARF) is common complication in ICU patients(Patients), which causes disturbance of homostasis of, electrolytes, acid-base balance with high mortality Rate, The principle cause of ARF especially in ICU ward are hypotension and Renal hypoperfusion and sepsis complications. This survey was performed with history taking, clinical and Paraclinical evaluation on 952 ICU patients from 21 Jan 1997 to 22 AGu 1999 Vali-Asr Hospital of Arak. From these pts 203 had different degree of ARF, 362 patients were female, 590 male, 5 patients had/chronic renal failure which omitted from study. From 198 patients with ARF 77 (38.9%) were female and 121 (61.1%) were male. Prevalence of ARF in male was 20.6% and in female was 21.4% sex difference is meaningless. The rate of ARF N in this study was 20.9% which there is no meaningful difference with report of western country (20-30). 110(55.5%) patients with ARF were being treated with one aminoglycoside and 66(33.3%) patients were taken aminoglycoside and cephalosporins concomitant compar 40(4.2%) patients with normal renal function. It seems that such nephrotoxic. Total mortality rate in ICU patients was 30.8% and in patients with ARF 116(50.6%) with meaningful difference with PV<0.0001, so ARf intensified most olity rate in ICU patients.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
